Tuberculosis a globalized disease: Review

  • Richard Owusu Nyarko School of medicine, American International University of West Africa.
  • Amit Prakash Department of Pharmacy,Invertis Institute of Pharmacy, Invertis University, Bareilly,UP, India.
  • Nayan Kumar Department of Pharmacy, Amity Institute of Pharmacy, Noida, India
  • Purabi Saha Department of pharmacy,   Uttaranchal Institute of Pharmaceutical Sciences., Dehradun, India
  • Roshan Kumar Department of Pharmacology, Dev Bhoomi Institute of Pharmacy and Research, Dehradun, India

Abstract

One of the deadliest infectious diseases in the world that causes millions of deaths per year is tuberculosis (TB). In this document we present an overview of TB including pathogenesis, diagnosis and recommendations for treatment. We searched PubMed for related articles on TB in preparation for this post. We have also checked for similar reporting and clinical recommendations on the websites of international organisations such as the World Health Organization and the United States Centers for Disease Control and Prevention (CDC). The aim of this paper was to give health staff, policy-makers, patients and the public general education.


 

Keywords: Tuberculosis (TB); drug-resistance; pathogenesis; drug therapy; infectious diseases

Downloads

Download data is not yet available.

Author Biographies

Richard Owusu Nyarko, School of medicine, American International University of West Africa.

School of medicine, American International University of West Africa.

Amit Prakash, Department of Pharmacy,Invertis Institute of Pharmacy, Invertis University, Bareilly,UP, India.

Department of Pharmacy,Invertis Institute of Pharmacy, Invertis University, Bareilly,UP, India.

Nayan Kumar, Department of Pharmacy, Amity Institute of Pharmacy, Noida, India

Department of Pharmacy, Amity Institute of Pharmacy, Noida, India

 

Purabi Saha, Department of pharmacy,   Uttaranchal Institute of Pharmaceutical Sciences., Dehradun, India

Department of pharmacy,   Uttaranchal Institute of Pharmaceutical Sciences., Dehradun, India

Roshan Kumar, Department of Pharmacology, Dev Bhoomi Institute of Pharmacy and Research, Dehradun, India

Department of Pharmacology, Dev Bhoomi Institute of Pharmacy and Research, Dehradun, India

References

1. World Health OrganizationGlobal tuberculosis report 2019
2. World Health Organization (2019)
3. Onozaki, et al.National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned Trop Med Int Health, 2015; 20(9):1128-1145
4. A.H. van't Hoog, et al.Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms PloS One, 7 (7) (2012), Article e38691
5. S. Den Boon, et al.An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys Int J Tubercul Lung Dis,2006; 10(8):876-882
6. M. Van Cleeff, et al.The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya BMC Infect Dis,2005; 5(1):1
7. M. van Cleeff, et al.A comprehensive study of the efficiency of the routine pulmonary tuberculosis diagnostic process in Nairobi Int J Tubercul Lung Dis, 2003; 7(2):186-189
8. S. Graham, et al.Chest radiograph abnormalities associated with tuberculosis: reproducibility and yield of active cases Int J Tubercul Lung Dis, 2002; 6(2):137-142
9. L.M. Pinto, et al.Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review Eur Respir J, 2013; 42(2):480-494
10. https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf

11. WHO’s annual rounds of global TB data collection and the annual WHO Global TB Report are key elements of “monitoring and reporting” in the WHO multisectoral accountability framework for TB.
12. Moliva, J.I.; Turner, J.; Torrelles, J.B. Immune responses to bacillus calmette–Guérin vaccination: Why do they fail to protect against mycobacterium tuberculosis? Front. Immunol. 2017, 8, 407.
13. Rich, A.R. The Pathogenesis of Tuberculosis, 2nd ed.; Charles C. Thomas: Springfield, IL, USA, 1951. 13. Koch, R. A Further Communication on A Remedy for Tuberculosis. Br. Med. J. 1890, 2, 1193–1199. 14. Koch, R. The First Communication Relating to a Method to Cure Tuberculosis; Birnbaum, M., Ed.; The Project Gutenberg: Salt Lake City, UT, USA, 1890.
14. 15. Medlar, E.M. A study of the process of caseation in tuberculosis. Am. J. Pathol. 1926, 2, 275–290.13
15. https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
16. World Health Organization. Consolidated action plan to prevent and combat multidrug- and extensively drugresistant tuberculosis in the WHO European Region 2011–2015. Conpenhagen, Denmark: WHO, 2011.
17. Thiam S, LeFevre AM, Hane F, et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA 2007; 297:380-6.
18. World Health Organization. Treatment of Tuberculosis, Fourth Edition. Geneva, Switzerland: WHO, 2010.
19. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1-77.
20. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children; Second Edition. Geneva, Switzerland: WHO, 2014.
21. Steichen O, Martinez-Almoyna L, De Broucker T. Isoniazid induced neuropathy: consider prevention. Rev Mal Respir 2006; 23:157-60.
22. Dhiman RK, Saraswat VA, Rajekar H, et al. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol 2012; 2:260-70.
23. Sonika U, Kar P. Tuberculosis and liver disease: management issues. Trop Gastroenterol 2012; 33:102
Statistics
77 Views | 83 Downloads
How to Cite
Nyarko, R., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease: Review. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201. https://doi.org/https://doi.org/10.22270/ajprd.v9i1.898